Abstract

Fourteen compounds were isolated from the root of Lindera reflexa Hemsl. Among these compounds, reflexan A (compound 1) was discovered to possess a novel skeleton and two stilbenes (compounds 2 and 3) were newly discovered compounds. Eleven known compounds (4–14) were also isolated, which included three alkaloids, one coumarin, four stilbenes, two flavonoids and katsumadain. The unusual structure of compounds 1, 2 and 3, along with their absolute configurations, was determined from UV, IR, HR ESI-MS, and 1D and 2D NMR data and by the comparison of experimental and calculated electronic circular dichroism (ECD) spectra. All of the isolates were tested with antitumor and anti-inflammatory assays. The results revealed that compounds 1, 2, and 3 all showed inhibitory activity toward three tumor cell lines, A549 (human lung carcinoma), BEL-7402 (human liver carcinoma) and HCT-8 (human colon carcinoma). None of the compounds exhibited anti-inflammatory activity.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.